
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+5
NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI) was formally established in Jan 2015 as the focal research program for synthetic biology at the National University of Singapore. SynCTI operates as a highly interdisciplinary research core that amalgamates leading Principal Investigators from Yong Loo Lin School of Medicine, the Faculty of Science and the Faculty of Engineering. Through research collaborations with renowned international institutes and private industries, SynCTI strives to create new knowledge and develop foundational technologies in synthetic biology and groom future generations of highly skilled researchers endowed with basic science and translational research capabilities
Education,medicine,research,synbio,biosensors,bio-manufacturing,therapeutic cells,synthetic genomics,environment remediation,and technology
Nus synthetic biology for clinical and technological innovation (syncti) operates in the Higher education industry.
Nus synthetic biology for clinical and technological innovation (syncti)'s revenue is 11m - 100m
Nus synthetic biology for clinical and technological innovation (syncti) has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.